Drug-eluting stents in renal artery stenosis

European Radiology

Volumn 18, Issue 4, 2008, Pages 678-682

  Zähringer, Markus ^e   Pattynama, P M T ^a   Talen, A ^b   Sapoval, M ^c,d  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Genae Associates nv   (Belgium)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d INSERM   (France)

^e MARIENHOSPITAL STUTTGART   (Germany)

Author keywords

Drug eluting stent; Paclitaxel; PTRA renal; Renal artery stenosis; Sirolimus

Indexed keywords

GOLD; METAL; PACLITAXEL; RAPAMYCIN;

ANGIOGRAPHY; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DRUG ELUTING STENT; DRUG MECHANISM; FOLLOW UP; HUMAN; IN-STENT RESTENOSIS; INTERMETHOD COMPARISON; KIDNEY ARTERY STENOSIS; PATIENT SAFETY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; REVASCULARIZATION; RISK REDUCTION; TREATMENT INDICATION; TREATMENT RESPONSE;

DRUG-ELUTING STENTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; RECURRENCE; RENAL ARTERY OBSTRUCTION; SIROLIMUS; TREATMENT OUTCOME;

EID: 41349086691     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-007-0789-5     Document Type: Article

References (34)

1. Missouris CG, Buckenham T, Cappuccio FP et al (1994) Renal artery stenosis: A common and important problem in patients with peripheral vascular disease. Am J Med 96:10-14
2. Gross CM, Krämer J, Waigand J et al (1998) Ostial renal artery stent placement for atherosclerotic renal artery stenosis in patients with coronary artery disease. Cathet Cardiovasc Diagn 45:1-8
3. Tollefson DFJ, Ernst CB (1991) Natural history of atherosclerotic renal artery stenosis associated with aortic disease. J Vasc Surg 14:327-331
4. Zierler RE, Bergelin RO, Davidson RC et al (1996) A prospective study of disease progression in patients with atherosclerotic renal artery stenosis. Am J Hypertens 9:1055-1061
5. Geyskes GG (1988) Treatment of renovascular hypertension with percutaneous transluminal renal angioplasty. Am J Kidney Dis 12:253-265
6. Ramsay LE, Waller PC (1990) Blood pressure response to percutaneous transluminal angioplasty for renovascular hypertension: An overview of published series. BMJ 300:569-572
7. Rees CR, Palmaz JC, Becker GJ et al (1991) Palmaz stent in atherosclerotic stenoses involving the ostia of the renal arteries: preliminary report of a multicenter study. Radiology 181:507-514
8. Harden PN, MacLeod MJ, Rodger RSC et al (1997) Effect of renal artery stenting on progression of renovascular renal failure. Lancet 349:1133-1136
9. Grüntzig A, Kuhlmann U, Vetter W et al (1978) Treatment of renovascular hypertension with percutaneous transluminal dilatation of renal artery stenosis. Lancet 1:801-802
10. Hoffmann O, Carreres T, Sapoval MR et al (1998) Ostial renal artery stenosis angioplasty: Immediate and mid-term angiographic and clinical results. J Vasc Interv Radiol 9:65-73
11. Grim CE, Luft FC, Yune HY et al (1981) Percutaneous transluminal dilatation in the treatment of renal vascular hypertension. Ann Intern Med 95:439-442
12. Baert AL, Wilms G, Amery A et al (1990) Percutaneous transluminal renal angioplasty: Initial results and long-term follow-up in 202 patients. Cardiovasc Intervent Radiol 13:22-28
13. Leertouwer TC, Gussenhoven EJ, Bosch JL et al (2000) Stent placement for renal arterial stenosis: Where do we stand. A meta-analysis. Radiology 216:78-85
14. Plouin PF (2003) Stable patients with atherosclerotic renal artery stenosis should be treated first with medical management. Am J Kidney Dis 42:851-857
15. Losito A, Errico R, Santirosi P et al (2005) Long-term follow-up of atherosclerotic renovascular disease. Beneficial effect of ACE inhibition. Nephrol Dial Transplant 20:1604-1609
16. van de Ven PJ, Kaatee R, Beutler JJ et al (1999) Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: A randomized trial. Lancet 353:282-286
17. Schillinger M, Minar E, Ahmadi R (2004) Treating renal artery stenosis. A statement pro endovascular therapy. Herz 29:68-75
18. Nolan BW, Schermerhorn ML, Powell RJ et al (2005) Outcomes of renal artery angioplasty and stenting using low-profile systems. J Vasc Surg 41:46-52
19. Sapoval M, Zähringer M, Pattynama P et al (2005) Low-profile stent system for treatment of atherosclerotic renal artery stenosis: The GREAT trial. J Vasc Interv Radiol 16:1195-1202
20. Zeller T, Rastan A, Kliem M et al (2005) Impact of carbon coating on the restenosis rate after stenting of atherosclerotic renal artery stenosis. J Endovasc Ther 12:605-611
21. Nolan BW, Schermerhorn ML, Powell RJ et al (2005) Restenosis in gold-coated renal artery stents. J Vasc Surg 42:40-46
22. Morice MC, Serruys PW, Sousa JE et al (2002) A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346:1773-1780
23. Moses JW, Leon MB, Popma JJ et al (2003) Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349:1315-1323
24. Duda Sh, Poerner TC, Wiesinger B et al (2003) Drug-eluting stents: potential applications for peripheral arterial occlusive disease. J Vasc Interv Radiol 14:291-301
25. Toutouzas K, Di Mario C, Falotico R et al (2002) Sirolimus-eluting stents: A review of experimental and clinical findings. Z Kardiol 91:49-57
26. Stone GW, Ellis SG, Cox DA (2004) One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: The TAXUS-IV trial. Circulation 109:1942-1947
27. Zähringer M, Sapoval M, Pattynama PMT et al (2007) Sirolimus-eluting versus bare-metal low-profile stent for renal artery treatment (GREAT trial): Angiographic follow-up after 6 month and clinical outcome up to 2 years. J Endovasc Ther 14:460-468
28. Zeller T, Müller C, Frank U et al (2003) Gold coating and restenosis after primary stenting of ostial renal artery stenosis. Catheter Cardiovasc Interv 60:1-6
29. Sacks D, Marinelli DL, Martin LG et al (1997) Reporting standards for clinical evaluation of new peripheral arterial revascularization devices. Technology Assessment Committee. J Vasc Interv Radiol 8:137-149
30. Lederman RJ, Mendelsohn FO, Santos R et al (2001) Primary renal artery stenting: Characteristics and outcomes after 363 procedures. Am Heart J 142:314-323
31. Bax L, Mali WP, Van De Ven PJ et al (2002) Repeated intervention for in-stent restenosis of the renal arteries. J Vasc Interv Radiol 13:1219-1224
32. Otah KE, Alhaddad IA (2004) Intravascular ultrasound-guided cutting balloon angioplasty for renal artery stent restenosis. Clin Cardiol 27:581-583
33. Neumann FJ, Desmet W, Grube E et al (2005) Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement. Circulation 111:2107-2111
34. Kakkar AK, Fischi M, Narins CR (2006) Drug-eluting stent implantation for treatment of recurrent renal artery in-stent restenosis. Catheter Cardiovasc Interv 68:118-122